Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
Covington
Mallinckrodt
Colorcon
Daiichi Sankyo
Healthtrust
Deloitte
McKesson

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019001

« Back to Dashboard

NDA 019001 describes BEPADIN, which is a drug marketed by Medpointe Pharm Hlc and is included in one NDA. Additional details are available on the BEPADIN profile page.

The generic ingredient in BEPADIN is bepridil hydrochloride. There are four drug master file entries for this compound. Additional details are available on the bepridil hydrochloride profile page.
Summary for 019001
Tradename:BEPADIN
Applicant:Medpointe Pharm Hlc
Ingredient:bepridil hydrochloride
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019001

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength200MG
Approval Date:Dec 28, 1990TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength300MG
Approval Date:Dec 28, 1990TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength400MG
Approval Date:Dec 28, 1990TE:RLD:No

Expired US Patents for NDA 019001

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-003 Dec 28, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-001 Dec 28, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-002 Dec 28, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
QuintilesIMS
McKesson
Deloitte
Healthtrust
Fish and Richardson
Chinese Patent Office
Express Scripts
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.